Question 1

Does Neuberger Berman own ALXN stock?

Accepted Answer

As of its Q2 2021 13F, Neuberger Berman held 769,228 shares of ALXN (Alexion Pharmaceuticals), worth $141.2M.

Question 2

How many shares of ALXN does Neuberger Berman own?

Accepted Answer

As of its Q2 2021 13F, Neuberger Berman held 769,228 shares of ALXN (Alexion Pharmaceuticals).

Question 3

What is Neuberger Berman's ALXN position worth?

Accepted Answer

As of its Q2 2021 13F, Neuberger Berman's ALXN position was worth $141.2M.

Question 4

When did Neuberger Berman first buy ALXN?

Accepted Answer

Neuberger Berman already held ALXN in its Q4 2018 13F, the earliest on record, and listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2021-Q2	Decreased	769,228	-4.3%	$141.2M	0.1%	—	0
2021-Q1	Decreased	804,040	-14.8%	$122.8M	0.1%	—	0
2020-Q4	Decreased	943,159	-17.8%	$147.3M	0.2%	—	0
2020-Q3	Increased	1.1M	+1.5%	$131.3M	0.2%	—	37
2020-Q2	Decreased	1.1M	-12.1%	$126.8M	0.2%	—	0
2020-Q1	Decreased	1.3M	-8.3%	$115.4M	0.2%	—	0
2019-Q4	Decreased	1.4M	-9.9%	$151.6M	0.2%	—	0
2019-Q3	Increased	1.6M	+33.1%	$152.4M	0.2%	—	46
2019-Q2	Increased	1.2M	+16.5%	$153.1M	0.2%	—	42
2019-Q1	Increased	1M	+15.0%	$135.6M	0.2%	—	41
2018-Q4	First report	872,144	-	$84.9M	0.1%	—	0